Spotlight

Huntington’s Disease Pivotal Program Modified to Less Frequent Dosing Easing Burden on Sites and Patients
More »

Latest Updates

Our commitment to develop transformational therapies for diseases both rare & common is represented through the groundbreaking work of Ionis' scientific leaders like Rosanne Crooke, PhD, who led the research efforts for the novel APO(a)-Lrx program #DrugDiscovery #LpaAwareness

Congratulations to our dear friend and colleague Dr. Nancy Wexler on this incredible honor! https://t.co/PGzfmOCbXQ

Follow us linkedin twitter
Ionis Clinical Trials

Clinical Trials

We have numerous ongoing clinical trials designed to evaluate our drugs in a variety of health conditions. More »